{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:02:24Z","timestamp":1762210944006},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jiph.2019.01.056","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T15:12:57Z","timestamp":1549811577000},"page":"496-501","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mutational analysis of gyrB at amino acids: G481A & D505A in multidrug resistant (MDR) tuberculosis patients"],"prefix":"10.1016","volume":"12","author":[{"given":"Nasir","family":"Mahmood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzada N.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelam","family":"Faraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saman","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2019.01.056_bib0005","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(06)68392-X","article-title":"WHO\u2019s new stop TB strategy","volume":"367","author":"Raviglione","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2019.01.056_bib0010","article-title":"First tuberculosis cases in Italy resistant to all tested drugs","volume":"12","author":"Migliori","year":"2007","journal-title":"Euro surveill"},{"key":"10.1016\/j.jiph.2019.01.056_bib0015","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.08-2427","article-title":"Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran","volume":"136","author":"Velayati","year":"2009","journal-title":"Chest J"},{"key":"10.1016\/j.jiph.2019.01.056_bib0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cid\/cir889","article-title":"Totally drug-resistant tuberculosis in India","volume":"54","author":"Udwadia","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2019.01.056_bib0025","article-title":"Tuberculosis-a review of clinical features, differential diagnosis and treatments available","volume":"2","author":"Kethireddy","year":"2010","journal-title":"Int J Pharm Technol"},{"key":"10.1016\/j.jiph.2019.01.056_bib0030","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1378\/chest.12-1286","article-title":"Mycobacterium tuberculosis septic shock","volume":"144","author":"Kethireddy","year":"2013","journal-title":"Chest J"},{"key":"10.1016\/j.jiph.2019.01.056_bib0035","first-page":"326","article-title":"Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan","volume":"12","author":"Javaid","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jiph.2019.01.056_bib0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrmicro2797","article-title":"Global tuberculosis control: lessons learnt and future prospects","volume":"10","author":"Lienhardt","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiph.2019.01.056_bib0045","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1469-0691.2010.03087.x","article-title":"First report of molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis isolates from a Tunisian hospital","volume":"16","author":"Soudani","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiph.2019.01.056_bib0050","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/dkr566","article-title":"A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system","volume":"67","author":"Maruri","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2019.01.056_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003426","article-title":"Detection and molecular characterization of 9000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean","volume":"3","author":"Hershkovitz","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.jiph.2019.01.056_bib0060","series-title":"Global tuberculosis report 2013","author":"Organization","year":"2013"},{"key":"10.1016\/j.jiph.2019.01.056_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2009.01.008","article-title":"Trends in Mycobacterium tuberculosis resistance, Pakistan , 1990-2007","volume":"13","author":"Hasan","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiph.2019.01.056_bib0070","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1128\/AAC.49.4.1483-1494.2005","article-title":"Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations","volume":"49","author":"Wiuff","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2019.01.056_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000002","article-title":"Tuberculosis drug resistance mutation database","volume":"6","author":"Sandgren","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jiph.2019.01.056_bib0080","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/AAC.01486-07","article-title":"Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin","volume":"52","author":"Safi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2019.01.056_bib0085","doi-asserted-by":"crossref","first-page":"20004","DOI":"10.1073\/pnas.0907925106","article-title":"Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis","volume":"106","author":"Zaunbrecher","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jiph.2019.01.056_bib0090","series-title":"Dictionary of genetics","author":"King","year":"2006"},{"key":"10.1016\/j.jiph.2019.01.056_bib0095","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1128\/AAC.37.10.2054","article-title":"Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis","volume":"37","author":"Telenti","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2019.01.056_bib0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1574-6976.2005.00002.x","article-title":"Role of mycobacterial efflux transporters in drug resistance: an unresolved question","volume":"30","author":"De Rossi","year":"2006","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jiph.2019.01.056_bib0105","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/AAC.48.11.4163-4170.2004","article-title":"Multidrug resistance of a porin deletion mutant of Mycobacterium smegmatis","volume":"48","author":"Stephan","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2019.01.056_bib0110","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/AAC.00239-08","article-title":"Role of porins for uptake of antibiotics by Mycobacterium smegmatis","volume":"52","author":"Danilchanka","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2019.01.056_bib0115","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tube.2008.02.004","article-title":"Identification of outer membrane proteins of Mycobacterium tuberculosis","volume":"88","author":"Song","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jiph.2019.01.056_bib0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev.bi.65.070196.001243","article-title":"Molecular mechanisms of drug resistance in Mycobacterium tuberculosis","volume":"65","author":"Blanchard","year":"1996","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jiph.2019.01.056_bib0125","article-title":"Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience","volume":"6","author":"Liu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jiph.2019.01.056_bib0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1128\/AAC.50.1.104-112.2006","article-title":"Novel gyrase mutations in quinolone-resistant and-hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes","volume":"50","author":"Aubry","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2019.01.056_bib0135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jiph.2019.01.056_bib0140","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/AAC.38.4.773","article-title":"Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations","volume":"38","author":"Takiff","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2019.01.056_bib0145","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/AAC.48.2.596-601.2004","article-title":"Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates","volume":"48","author":"Cheng","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2019.01.056_bib0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijantimicag.2007.10.014","article-title":"Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates","volume":"31","author":"Sun","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2019.01.056_bib0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jinf.2010.05.001","article-title":"Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China","volume":"61","author":"Yin","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jiph.2019.01.056_bib0160","series-title":"Pakistan \u2014 tuberculosis","author":"WHO, Eastern Mediterranean","year":"2018"},{"key":"10.1016\/j.jiph.2019.01.056_bib0165","first-page":"228","article-title":"Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand","volume":"36","author":"Pitaksajjakul","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.jiph.2019.01.056_bib0170","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/358591a0","article-title":"The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis","volume":"358","author":"Zhang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jiph.2019.01.056_bib0175","first-page":"269","article-title":"Cross-resistance relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis","volume":"88","author":"Tsukamura","year":"1975","journal-title":"Microbiology"},{"key":"10.1016\/j.jiph.2019.01.056_bib0180","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1128\/AAC.00851-09","article-title":"High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene","volume":"53","author":"Jugheli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2019.01.056_bib0185","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.molcel.2006.05.044","article-title":"Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2\u2032-O-methylations in 16S and 23S rRNAs","volume":"23","author":"Johansen","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.jiph.2019.01.056_bib0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tube.2013.02.005","article-title":"Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels","volume":"93","author":"Chernyaeva","year":"2013","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jiph.2019.01.056_bib0195","doi-asserted-by":"crossref","first-page":"O14","DOI":"10.1186\/1471-2334-14-S3-O14","article-title":"A novel gyrB gene mutation in fluoroquinolone resistant clinical isolates of Mycobacterium tuberculosis","volume":"14","author":"Singh","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2019.01.056_bib0200","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1128\/AAC.00541-09","article-title":"Beiing genotype of Mycobacterium tuberculosis is significantly associated with high-level Fluotoquinolone resistance in Vietnam","volume":"11","author":"An","year":"2009","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034119300589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034119300589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T04:01:47Z","timestamp":1576900907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034119300589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1876034119300589"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2019.01.056","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutational analysis of gyrB at amino acids: G481A & D505A in multidrug resistant (MDR) tuberculosis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2019.01.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}